Molecular Epidemiology of Staphylococcus epidermidis Clinical Isolates from U.S. Hospitals

Ítems similars

• Oritavancin Activity against Staphylococcus aureus Causing Invasive Infections in U.S. and European Hospitals: a 5-Year International Surveillance Program
  per: Mendes, Rodrigo E., et al.
  Publicat: (2014)
• Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014
  per: Farrell, David J., et al.
  Publicat: (2016)
• Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016
  per: Sader, Helio S., et al.
  Publicat: (2017)
• Baseline Activity of Telavancin against Gram-Positive Clinical Isolates Responsible for Documented Infections in U.S. Hospitals (2011-2012) as Determined by the Revised Susceptibility Testing Method
  per: Mendes, Rodrigo E., et al.
  Publicat: (2014)
• Prevalence of β-Lactamase-Encoding Genes among Enterobacteriaceae Bacteremia Isolates Collected in 26 U.S. Hospitals: Report from the SENTRY Antimicrobial Surveillance Program (2010)
  per: Castanheira, Mariana, et al.
  Publicat: (2013)